Inactive Instrument

Nissui Pharmaceutical Co., Ltd. Stock

Equities

4550

JP3678100003

Dynamic Chart
MiCAN Technologies Inc. announced that it has received ¥50 million in funding from Nissui Pharmaceutical Co., Ltd. CI
Nissui Pharmaceutical Co., Ltd.(TSE:4550) dropped from S&P Global BMI Index CI
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022. CI
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022. CI
Nissui Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 31, 2022 has closed with 12,552,248 shares, representing 55.67% for ¥20,861.84 CI
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion. CI
Nissui Pharmaceutical Co., Ltd. announces an Equity Buyback for 13,237,063 shares, representing 58.71% for ¥22,000 million. CI
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion. CI
Nissui Pharmaceutical Co., Ltd. authorizes a Buyback Plan. CI
Nissui Pharmaceutical Co., Ltd. cancelled the acquisition of 10% stake in Nihon Techno Service Co., Ltd. from Takashi Masaki. CI
Zeria Pharmaceutical Co., Ltd. cancelled the agreement to acquire Nissui Pharm Medical Sales Co., Ltd. from Nissui Pharmaceutical Co., Ltd.. CI
Nissui Pharmaceutical Co., Ltd.(TSE:4550) added to S&P Global BMI Index CI
Nissui Pharmaceutical Co., Ltd. agreed to acquire 10% stake in Nihon Techno Service Co., Ltd. from Takashi Masaki. CI
Nihon Techno Service Co., Ltd. announced that it has received funding from Nissui Pharmaceutical Co., Ltd. CI
Zeria Pharmaceutical Co., Ltd. entered into an agreement to acquire Nissui Pharm Medical Sales Co., Ltd. from Nissui Pharmaceutical Co., Ltd. for ¥3.3 billion. CI
More news
Managers TitleAgeSince
Chief Executive Officer 61 86-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 97-05-31
Chief Executive Officer 61 86-03-31
Director/Board Member 61 17-09-30
More insiders
Nissui Pharmaceutical Co.,Ltd. is a Japan-based company mainly engaged in the manufacture, purchase and sale of clinical diagnostic drugs, industrial diagnostic drugs, pharmaceuticals, among others. The Company operates through two business segments. The Diagnostic Drug segment is involved in the manufacture, purchase and sale of culture media, clinical diagnostic drugs, industrial diagnostic drugs and raw materials for medical institutions, research institutions and industrial facilities, as well as the purchase and sale of testing equipment and other equipment. The Pharmaceutical segment is involved in the manufacture, purchase and sale of pharmaceuticals and health foods for pharmacies and drugstores. The Company's main products include clinical diagnostic drugs, industrial diagnostic drugs such as compactdry, pharmaceuticals such as therapeutics, nourishing tonics and health foods.
Sector
-
More about the company